Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.

MLA

Chaparro, María, et al. “Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab.” Journal of Clinical Medicine, vol. 11, no. 15, Aug. 2022. EBSCOhost, https://doi.org/10.3390/jcm11154518.

APA

Chaparro, M., Baston-Rey, I., Fernández Salgado, E., González García, J., Ramos, L., Diz-Lois Palomares, M. T., Argüelles-Arias, F., Iglesias Flores, E., Cabello, M., Rubio Iturria, S., Núñez Ortiz, A., Charro, M., Ginard, D., Dueñas Sadornil, C., Merino Ochoa, O., Busquets, D., Iyo, E., Gutiérrez Casbas, A., Ramírez de la Piscina, P., … Gisbert, J. P. (2022). Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab. Journal of Clinical Medicine, 11(15). https://doi.org/10.3390/jcm11154518

Chicago

Chaparro, María, Iria Baston-Rey, Estela Fernández Salgado, Javier González García, Laura Ramos, María Teresa Diz-Lois Palomares, Federico Argüelles-Arias, et al. 2022. “Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab.” Journal of Clinical Medicine 11 (15). doi:10.3390/jcm11154518.